L. Groban et al., Thoracic epidural anesthesia reduces infarct size in a canine model of myocardial ischemia and reperfusion injury, J CARDIOTHO, 13(5), 1999, pp. 579-585
Objective: To determine the effects of thoracic epidural anesthesia on myoc
ardial infarct size, regional myocardial blood flow (RMBF), and plasma nore
pinephrine in an anesthetized canine model of ischemia reperfusion injury w
ith infarction.
Design: Blinded, randomized, placebo-controlled animal study.
Setting: Experiments were performed in the cardiothoracic research laborato
ry at Wake Forest University Baptist Medical Center.
Participants: Anesthetized, open-chest mongrel dogs were used in these stud
ies.
Methods: Dogs were instrumented for measurement of aortic pressure (AP) and
left ventricular systolic pressure (LVSP), dP/dt, and RMBF. Epidural cathe
ters were inserted at thoracic segment T5. Three groups received epidural 0
.5% bupivacaine: low-dose (0 = 7; 0.3 mg/kg bolus, 0.15 mg/kg/h), mid-dose
(0 = 7; 0.6 mg/kg bolus, 0.3 mg/kg/h), high-dose (0 = 7; 1.2 mg/kg bolus, 0
.6 mg/kg/h). The vehicle (VEH) group received epidural saline. Bolus follow
ed by maintenance infusions began 30 minutes before the onset of ischemia (
60 min) and continued through reperfusion (180 min).
Results: Myocardial infarct size was significantly reduced in the high-dose
group versus the VEH and low-dose groups (p < 0.05). After initiation of t
he mid and high dose, AP, LVSP, and dP/dt decreased 7% to 16% (high v VEH;
p < 0.05). VEH dogs showed a 130% increase from control in early postischem
ic RMBF. There was a dose-dependent attenuation in this reflow response: 72
%, 31%, and 6% increase in RMBF in the low, mid, and high groups, relative
to controls (p < 0.05 high v VEH). Although there was no significant differ
ence in plasma norepinephrine, fewer surges occurred in the high-dose group
.
Conclusions: Thoracic epidural anesthesia reduces infarct size and postisch
emic hyperemia in a model of ischemia reperfusion injury. Copyright (C) 199
9 by W.B. Saunders Company.